ICAS World, a leading global provider of Employee Assistance Programmes (EAP), crisis management solutions and people development, will use a significant investment from the alternative lender BOOST&Co to drive its future growth and fund further acquisitions, after demand for its services surged in the wake of a growing awareness of
Ropes & Gray has advised Acceleron in its USD11.5 billion sale to Merck & Co. This is one of Merck’s biggest acquisitions and diversifies the pharmaceutical company’s pipeline by adding Acceleron’s drugs to target rare diseases. The transaction was announced on 30 September.
Biotechnology company Expansion Therapeutics has closed an USD80 million Series B financing led by Cormorant Asset Management with participation from new investors Westlake Village BioPartners, Surveyor Capital (a Citadel company) and Logos Capital as well as Series A investors RA Capital Management, 5AM Ventures, Kleiner Perkins, Sanofi Ventures and Novartis
CVC Credit has further supported life sciences and diagnostics business, Calibre Scientific, by leading an incremental USD57 million multi-currency first lien credit facility to help fuel its ongoing global acquisition strategy. Calibre Scientific is owned by investment firm StoneCalibre. CVC Credit originally provided a USD92 million multi-currency first lien credit
NovaSignal Corp, a medical technology and data company specialising in the assessment and management of brain health, has closed a USD37 million Series C1 funding round. The company will use the capital to support NovaSignal’s continued commercial expansion, consistent delivery of product innovation, and new clinical trials to increase indications
Intriva Capital, an independent alternative asset manager, has acquired Sequence Care Group (Sequence), a provider of high-quality specialist care services that enable adults with complex learning disabilities to live richer, happier lives. Sequence’s highly experienced management team will roll their investment alongside Intriva, to continue to drive high-quality care outcomes
Healthcare technology company Stellar Health (Stellar) has raised over USD60 million in a Series B funding round led by General Atlantic, with participation from Point72 Ventures and Primary Venture Partners, who led Stellar’s Series A financing in 2020. New investors also include Mike Pykosz and Geoff Price, two of the
Sanome, a European health start-up, has raised GBP2 million as its first round of funding from a number of leading UK and European HealthTech specialist investors. The round was led by Heal Capital, with participation from Crista Galli Ventures, Selvedge Ventures, o2h Ventures, Meltwind and a number of high-profile angels
Amulet Capital Partners (Amulet), a middle-market private equity investment firm based in Greenwich, Conneticut, focused exclusively on the healthcare sector, has acquired Remedy Health Media (Remedy), a digital health platform that serves patients, caregivers and healthcare providers through a family of trusted health information websites. Amulet acquired Remedy from Topspin
Vision Innovation Partners, an eye care platform, has acquired See Clearly Vision, an eye care practice with locations in Tysons Corner and Arlington, Virginia. The acquisition expands Vision Innovation Partners’ presence in the Washington DC metropolitan area and further enhances its growing network of ophthalmology practices and ambulatory surgery centres
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
